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The CagA toxin of Helicobacter 
pylori: abundant production but 
relatively low amount translocated
Luisa F. Jiménez-Soto1 & Rainer Haas1,2
CagA is one of the most studied pathogenicity factors of the bacterial pathogen Helicobacter pylori. 
It is injected into host cells via the H. pylori cag-Type IV secretion system. Due to its association with 
gastric cancer, CagA is classified as oncogenic protein. At the same time CagA represents the 4th most 
abundant protein produced by H. pylori, suggesting that high amounts of toxin are required to cause 
the physiological changes or damage observed in cells. We were able to quantify the injection of CagA 
into gastric AGS epithelial cells in vitro by the adaptation of a novel protease-based approach to remove 
the tightly adherent extracellular bacteria. After one hour of infection only 1.5% of the total CagA 
available was injected by the adherent bacteria, whereas after 3 hours 7.5% was found within the host 
cell. Thus, our data show that only a surprisingly small amount of the CagA available in the infection is 
finally injected under in vitro infection conditions.
Bacteria have developed several mechanisms to secrete proteins or to inject toxins into target cells. Helicobacter 
pylori, a bacterial pathogen associated with gastric pathologies, uses the cag Type IV secretion system (cag-T4SS) 
to inject the cytotoxin-associated antigen A (CagA) into host cells1. Once inside the cell, CagA is phosphorylated 
by the cellular Src and Abl kinases in the Glu-Pro-Ile-Tyr-Ala (EPIYA) motifs found on the C-terminal half of 
the protein2,3. Injected phosphorylated CagA is targeted to the apical junctional complex of the epithelial cell 
monolayer through the N terminus of the molecule4. Notably, CagA is sufficient to disrupt the mechanisms that 
maintain normal epithelial differentiation, including cell adhesion, cell polarity, and the inhibition of cell migra-
tion5. Via its phosphorylated EPIYA motifs CagA interacts with a large number of host cell proteins carrying 
SH2 domains6, which results in cytoskeleton rearrangements and in deregulation of several signal transduction 
pathways. All these effects appear to be controlled by different domains in the CagA protein, some of which are 
phosphorylation-dependent, especially those interfering with signaling cascades, whereas those which relate to 
the apical junctions are phosphorylation-independent4.
In order to achieve an efficient injection of CagA into the cell, H. pylori requires the Integrin Beta 1 (ITGB1) 
as receptor for the T4SS and a tight interaction with the surface of the cell achieved through the adhesins present 
on the bacterial surface7,8. From the many adhesins present in H. pylori, BabA, SabA, AlpA/B, and OipA are those 
studied most. They recognize special carbohydrates on the surface of epithelial cells, such as Lewis b (BabA) 
or sialyl-Lewis x (SabA)9. Recently also the HopQ adhesin has been added to the list and shown to support the 
injection of CagA10.
The CagA protein is the 4th most abundant protein produced by H. pylori strain 26695, ranging behind GroEL 
(Hp0010), UreB (Hp0072) and TsaA (Hp1563)11. Since CagA is the only effector protein known being injected 
by the cag-T4SS, these very high quantities of CagA protein produced by H. pylori imply that a high amount of 
CagA can be injected into eukaryotic cells in order to see the effects described above. Having this in mind, we 
wanted to determine how much CagA is really injected during in vitro infection of H. pylori in comparison to the 
total amount of CagA produced. However, a quantitative approach to determine how much CagA is injected into 
the host cell has not been described. This is in contrast to Salmonella species using a Type III secretion system for 
effector protein injection12,13. In some of these systems the removal of adherent bacteria was achieved by different 
washing steps, which is not possible for H. pylori because of its tight binding to AGS cells. We therefore devel-
oped a novel procedure, which makes use of Proteinase K digestion to remove all bacteria from the surface of the 
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cells without damaging the integrity of the eukaryotic cell. Using this technique and semi-quantitative analysis 
of western blots we have determined the amounts of CagA injected in the host cells during infection of gastric 
epithelial AGS cells in vitro.
Results
Proteinase K treatment removes bound bacteria from infected AGS cells. H. pylori shows a tight 
binding to host cells, which is mediated by a variable set of highly efficient bacterial adhesins14. This tight inter-
action of the bacteria with the cells does not allow removal of bacteria after infection by conventional physical 
methods without damaging the host cells. For this we developed a Proteinase K digestion protocol that achieves 
removal of bacteria without causing damage to the integrity of the membrane of the eukaryotic cell. The integrity 
of the eukaryotic cells was tested using propidium iodine (data not shown). We used serum-starved gastric ade-
nocarcinoma epithelial cells (AGS) after 30 min of serum addition, at which point a high amount of ITGB1 was 
present on the surface of the cells. The infection proceeded for 1 or 3 hours with a multiplicity of infection (MOI) 
of 30. This was the lowest MOI to be used in a one hour infection experiment of synchronized cells allowing the 
immunodetection of the phosphorylated form of CagA. Higher MOIs did not allow a complete removal of H. 
pylori from AGS cells without causing severe damage of the host cell membrane by extended digestion times. 
Cells were then harvested by scrapping (Traditional, Trad), by Trypsin-EDTA detachment (TE/ Trypsin) or by 
Proteinase K digestion (PK) in 16 °C, to block uptake of bacterial fragments by the cell via endocytosis (Fig. 1A). 
To verify the removal of bacteria, we infected cells with an H. pylori strain expressing GFP in the cytoplasm 
(strain P12 GFP)7,15. After one hour of infection, cells were harvested, washed and the amount of bound bacteria 
was analyzed by flow cytometry. As shown in Fig. 1B, the proteinase K treatment removed all GFP signals, while 
TE treatment reduced about 40% of the signals in comparison to the traditional harvest, which represents all 
bacteria that remain bound to cells after the infection time and subsequent washing steps.
To extend the procedure to another H. pylori (strain 26695) and to verify that all bacterial proteins on the cell 
surface were removed as well, infected AGS cells were harvested using the different procedures described, and 
Figure 1. Establishment of different harvesting methods for the quantification of CagA injection. 
(A) Schematic representation of the experimental setup explained in Material and Methods section. (B) 
GFP expressing P12 strain (P12 GFP) infected AGS cells for one hour. Cells were harvested by scrapping 
(Traditional, Trad), Trypsin-EDTA (TE) or Proteinase K (PK) digestion. Mean fluorescence Units are shown 
here. Cells without infection are shown as control for changes in fluorescence caused by the different treatments. 
n = 3, ANOVA used for the statistical analysis. *P < 0.05, ***P < 0.001. Histograms are representative of data 
obtained. (C) Immunodetection of bacterial proteins phosphorylated CagA (Ⓟ-CagA, 4G10), CagA (AK268), 
RecA (AK263), AlpB, and cellular protein Tubulin. All detections shown here were done from the same blot 
transfer. Bacteria lysates from strain 26695 (and ΔCagPAI) were used as control for the western blots.
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the lysates were analyzed by western blot for the presence of bacterial proteins RecA (cytoplasmic), AlpB (outer 
membrane) and CagA (cytoplasmic / outer membrane). RecA and AlpB were absent from the samples treated 
with Proteinase K only and the AlpB signal was strongly reduced by Trypsin-EDTA treatment. The tubulin signal 
shows that intracellular host cell proteins were conserved during the different treatments and harvest methods 
(Fig. 1C).
Bacterial CagA is removed, but injected phosphorylated CagA is conserved after proteinase K 
treatment. After one hour of infection, the signals for the phosphorylated form of CagA (Ⓟ-CagA) stayed 
rather constant in all treatment/harvest methods. However the signals detecting the CagA protein (CagA) 
are strongly reduced after proteinase K treatment (Fig. 1C). Quantification of the corresponding bands in 
the western blot (Fig. 2A) from three different experiments normalized to the signals of the traditional har-
vest after one hour infection clearly demonstrates that the procedure efficiently removed CagA in the bacteria 
bound to the cells. However the injected and phosphorylated CagA was completely protected, as no changes on 
CagA-phosphorylation signals were observed (Fig. 2B).
We next determined the amount of CagA after 3 hours of infection, since at this time point the effects on 
cytoskeletal changes caused by CagA translocation (e.g. hummingbird phenotype) are visible. Notably, the same 
conservation of CagA phosphorylation was observed with the different harvest treatments at the 3 hours time 
point (Fig. 2C). In contrast to the 1 hour infection, the levels of total CagA protein present in the lysates after 
Trypsin EDTA treatment (protease control treatment) of the 3 hour infections reached only 71% of the signal 
achieved with the traditional harvest.
In a further step we quantified translocated (phosphorylated CagA protein signal (Ⓟ-CagA)) versus total 
available/detected CagA (CagA protein signal (CagA)) and normalized it to the traditional harvest signals (which 
represent the bacteria adherent to the AGS cells, and all CagA available during the infection). After one hour of 
infection the CagA signal present after the total removal of bacteria, meaning that it is present inside the AGS 
cells, corresponded to approx. 16% of the total CagA signal observed in the traditional or TE treatments. As 
expected, after 3 hours of infection there was a higher amount of CagA protein inside the cell, corresponding to 
roughly 30% of the total CagA signal of the traditional harvest (Fig. 2C). Furthermore, after 3 hours of infection 
the CagA signal during TE treatment diminished (Fig. 2C), in contrast to the analysis of the signals of one hour 
Figure 2. Quantification of signals for phosphorylated CagA (Ⓟ-CagA) and CagA. Infection times were 
chosen for 1 hour (A,B) or 3 hours (C,D). Densitometry analysis of the signals from the immunodetection of 
CagA and its phosphorylated form Ⓟ-CagA. Signals from traditional harvest by scrapping (Trad) were used 
as normalization parameter stabilizing the 100% of the signals to be obtained. Signals obtained from samples 
digested Trypsin EDTA and Proteinase K are shown relative to the traditional harvest. Single examples of the 
blots for each time point are shown as well (B,D). All densitometry values were normalized to the Stain Free 
signal.
www.nature.com/scientificreports/
4Scientific RepoRts | 6:23227 | DOI: 10.1038/srep23227
infections, which did not show visible differences between Traditional harvest and TE. We hypothesize that dur-
ing the three hours of infection, more CagA will be transported onto the surface of the bacteria and in this way 
it will be susceptible for digestion by trypsin. We tried to verify this by immunodetection of CagA comparing 
the one hour vs. the three-hour infection signals, but the Trypsin EDTA treatment of infected cells caused an 
unspecific binding of the antibodies to eukaryotic cells making it impossible for detection (data not shown). 
Remarkably, regardless of the time point or the kind of harvest, there was no difference in the signals detecting 
the phosphorylated CagA protein, which corroborated the comparability and reproducibility of the method used.
Only a low percentage of H. pylori bacteria are ready to interact with ITGB1. The cag-T4SS injects 
CagA in the host cell after interaction with ITGB17,8. Based on the data above, the low amount of injected CagA 
will indicate a low CagA translocation capacity or a low number of Cag T4SS apparatus able to inject the toxin. 
To determine the amount of bacteria grown on plates ready to interact with the T4SS receptor ITGB1, we looked 
at the amount of bacteria interacting with Integrin beta 1 alpha 5 (ITGB1A5)-coated magnetic beads (scheme in 
Fig. 3A). Based on our previously published AGS cell co-infection experiments with different H. pylori strains 
and their consequences for CagA translocation15, we assume that the interaction of the assembled Cag apparatus 
with the ITGB1 has to be a fast process. Therefore the interaction was tested using a window of 5 min for binding. 
Our results show that approx. 5% of the bacteria growing on media free of serum proteins show the ability to 
interact directly with the ITGB1 beads (Fig. 3B) in these 5 minutes of contact. We conclude that under these in 
vitro growth conditions of H. pylori 26695 only 5% of the bacteria have the Cag apparatus fully assembled and 
ready for integrin interaction.
A low percentage of H. pylori is able to bind tightly to AGS cells after 1 and 3 hour infections. 
The translocation of CagA requires not only a functional secretion system, but equally important requires a cer-
tain capacity of adhesion of the bacteria to the host cell, as it has been shown for certain outer membrane proteins 
Figure 3. Availability of Cag apparatus and binding capacity of H. pylori in infection assays. (A) Scheme for 
the binding test of strain 26695 to ITGB1A5 coated beads (See Material and Methods). (B) Percentage of colony 
forming units recovered after binding assay to ITGB1A5 coated magnetic beads, relative to the total amount of 
bacteria present in the initial suspension. n = 4. T-test was used for the statistical analysis. (C,D) Quantification 
of RecA signals by densitometry analysis and after normalization to stain free signals, the percentage were 
calculated relative to the signals given by the lysates of the original amount of bacteria. Statistical analysis 
applied was one way ANOVA, with post-Turkey test for comparison between each different treatment. n = 3. 
*P < 0.05; **P < 0.01; ***P < 0.001, ns (not significant) P > 0.05.
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influencing the capacity of CagA translocation10,16. Therefore we determined the amount of bacteria bound to 
the cells by quantitative analysis of the RecA signals compared to the total RecA signals of the bacteria added at 
the moment of infection. The RecA signal of the bacteria bound to the cells harvested by scrapping (Traditional 
harvest, Trad) after one hour represents only 9.3% of the total signal obtained by all bacteria used for infection 
(Fig. 3C). Although the Trypsin EDTA treatment seems to leave only 4.6% of the signal, it is not statistically sig-
nificant to the traditional harvest signal. As expected after Proteinase K treatment, no quantifiable signal could 
be detected. In the case of three hour infection (Fig. 3D), there are equally higher signals of RecA for both harvest 
systems, the Traditional and Trypsin-EDTA. We can conclude from these data that the longer the in vitro infec-
tion takes place, the better will be the binding of the bacteria to the cells and more CagA is translocated, explain-
ing the rise in translocated CagA from 16% to 30%. However it is important to highlight that only a small fraction 
of the total amount of bacteria added to the infection assay are able to bind to cells during the two infection times 
tested.
Discussion
Over the years many functions have been assigned to the CagA toxin of Helicobacter pylori. Among others it 
confers advantage to bacteria during infection of host tissue in iron-deficient conditions17, it causes changes on 
the chemokine profile of tissue increasing inflammation14, it induces alteration of the immune system by affecting 
the survival of B cells18 and changes the histological characteristics of the stomach19. All these effects of CagA 
are thought to finally lead to the formation of gastric cancer. It is therefore necessary to know the real amount of 
CagA entering the cells to evaluate its effectiveness. By removing the bacteria from the surface, we can not only 
evaluate the amount of CagA injected into the host cell, but we also can infer on the efficiency of the injected toxin 
by analyzing the amount of bacteria that remain tightly attached to the AGS cells. Since H. pylori needs to attach 
to the cells in order to inject the CagA, we used the analysis of the RecA protein signal to determine the percent-
age of bacteria tightly bound to the cells after the different infection times. From the initial amount of bacteria 
added, about 4–9% bound tightly to the cells after 1 hour of infection and 25% after 3 hours. At the same time, the 
amount of CagA injected after one hour was around 16% of the total CagA present in the adherent bacteria, and 
30% after three hours. Considering total amount of bacteria in the infection and the amount of CagA injected by 
the bound bacteria we can assume that after one hour only 1.5% of the total CagA present in all bacteria during 
the in vitro infection is injected into the host cell and after 3 hours, 7.5% of the total CagA has been injected. 
The relatively low amount of injected versus total CagA, especially in the 1 hour infection experiments, may 
be explained as the product of a low number of bacteria having the Cag T4SS functionally assembled on their 
surface (~5%) and the low number of adherent bacteria (~4–9%). These values demonstrate how successful the 
toxin can be in modifying the cultured cells despite its small amount. Additionally, although we cannot define 
a kinetic of injection with two time points, it is interesting to observe that the more the bacteria are able to bind 
to the cells, the higher is the amount of CagA present inside them, confirming the necessity of binding for CagA 
translocation.
An important question arising is how do the in vitro CagA translocation results relate to the in vivo behav-
ior of the bacteria? So far no reliable method has been described showing CagA translocation and its quantifi-
cation under in vivo conditions in the infected host or experimental animal. We therefore cannot mirror any 
in vitro CagA translocation data with the situation in vivo. However the molecular mechanisms involved can be 
better understood in cell culture experiments and they have been used as a valid approximation to the situation 
in vivo. Also the question whether all CagA translocated into the host cell will be phosphorylated by the host 
cell kinases has to be left open. Each status of CagA might have its function, especially since phosphorylated and 
non-phosphorylated CagA (e.g. the latter with non-phosphorylatable EPIFA motif) have been reported to affect 
different cellular processes once inside the cell4,20,21. Furthermore, we cannot exclude that these large quantities of 
CagA toxin might have other functions besides its role in the host cell cytoplasm. Since CagA has been considered 
to be toxic only after injection into the cytoplasm of the host cell by a functional T4SS, the question arises what 
happens to the non-injected CagA? Does it stay in the bacteria? We know that small amounts are located on the 
bacterial surface. Can it also be secreted into the local “environment” during an infection? Would it be taken up 
by immune cells? Another aspect to be considered is a kind of regulation of CagA injection. We recently have 
discovered a bacteria-induced resistance mechanism of the cell to CagA injection15. Is the rather low amount of 
translocated CagA the result of a cellular “bottleneck” or a self-limitation of the bacteria to avoid a too strong 
damage of the host cell? Future studies should answer these and other unsolved questions around the role of 
CagA toxin in the relationship between host and H. pylori.
Materials and Methods
Bacteria strains and culture. The H. pylori strain P12 was isolated from a duodenal ulcer patient, and to 
produce a GFP protein it has been inserted a pHel4 plasmid containing the GFPmut3 protein under the AlpA 
promoter. The strain 26695 is a lab strain. The mutants 26695 Δhp0547(cagA), Δhp0527(cagY) and Δhp0544(cagE) 
have been already described22. All H. pylori strains were grown on GC agar plates supplemented with a choles-
terol/lipid mix (Gibco, Life Technologies) and vitamin mix as described23. All antibiotics were obtained from 
Sigma-Aldrich (Deisenhofen, Germany). Incubation of the bacteria was performed at 37 °C for 24 hours in an 
anaerobic incubator containing a controlled atmosphere composed of of 5% O2, 10% CO2 and 85% N2 (Oxoid, 
Wesel, Germany).
Binding assays with Magnetic beads. Chemicell magnetic beads were coated with recombinant 
ITGB1A524 following the 2-step protocol recommended by the manufacturer. As blocking buffer we used 25 mM 
Tris-HCl pH7.5 (BSA shows unspecific binding to H. pylori). Bacteria were suspended in PBS buffer (Ca-, Mg-) 
from Gibco and OD550 measured. Bacteria suspension of OD550 0.1 were exposed to 10 μl of beads for 5 min and 
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thoroughly washed three times. Serial dilutions were plated from the original OD550 0.1 and the magnetic beads 
suspended in 1 ml. After plating of bacterial suspensions, they were incubated for 5 days at 10% CO2, 37 °C and 
colony forming units (CFUs) were quantified.
Infections assay. All infections were done as described15. Shortly, we used AGS cells (ATCC CRL 1739a 
human gastric adenocarcinoma epithelial cell line) grown on 6-well plates in RPMI media for at least 36 hours 
in 5% CO2, 37 °C to a density of approx. 80% confluence, and incubated further in serum-free media for at least 
8 hours. Before infection, cells were incubated for 30 min in serum containing RPMI media (Complete media, 
CM) and infected with an MOI of 30 for 1 or 3 hours at 37 °C in 5% CO2.
Harvest methods. At the moment of harvest, all cells were placed on ice, and washed twice with 2 ml cold 
PBS (Ca-, Mg-; Gibco, Life Technologies). Three treatments were used for harvest: i) Traditional (Trad), in which 
the cells were placed 5 hours in 16 °C and collected using cell scrapers to remove them from the growth surface 
in 1 ml cold PBS containing 1 mM PMSF, 1 mM Sodium Ortho-vanadat, 1 μM Leupetin and 1 μM pepstatin. 
ii) Trypsin-EDTA (TE), in which cells were removed from the surface using 0.5 ml of Trypsin-EDTA solution 
(Gibco, Life Technologies) and incubated for 5 hours at 16 °C, at which time they had lost adherence to the growth 
surface and where collected. iii) Proteinase K digestion, which it was achieved using 1 ml per well of a 10 mg/ml 
crude Proteinase K (Sigma) in Proteinase K buffer (50 mM Tris-HCl pH 7.5, 150 mM NaCl, 1 mM CaCl2, 1 mM 
MgCl2, 1 mM KCl) for 5 hours at 16 °C, after which cells were detached from the growth surface.
All detached cells through protease treatment, were collected and mixed 1:1 with a cold PBS solution contain-
ing 2 mM PMSF to inactivate the activity of the proteases. After all samples were collected, they were centrifuged 
once at 200 g 4 °C for 10 min in a swing rotor centrifuge. Pellets were washed 5 times using 1 ml cold PBS 1 mM 
PMSF with centrifugation steps of 10 min 100 g at 4 °C in a swing rotor centrifuge. Pellets were finally resus-
pended in 20 μl of PBS containing proteinase inhibitors and mixed with 25 μl of 2X SDS loading buffer. Samples 
were boiled for 10 min at 95 °C and store at − 20 °C until needed.
Flow cytometry. Infections and harvest were done as explained previously. For the conservation and sta-
bilization of samples, after the last washing step, pellets were suspended in PBS containing 1% PFA solution and 
analyzed using a BD Canto II flow cytometer. For the statistical analysis, mean fluorescent units from each treat-
ment were normalized to their controls (uninfected cells) and analyzed using an ANOVA one way analysis. The 
histograms are representative of data obtained in the experiments.
Western blots and quantification of signals. Proteins were separated by 6% and 7% SDS-PAGES 
(Single gel system by Ahn T25 and blotted on PVDF membranes (Bio-Rad). CagA was detected with rabbit 
polyclonal antibodies against the N- or the C-terminal part and phosphorylated CagA and mouse monoclonal 
α -phosphotyrosine antibody 4G10 (Millipore/Upstate). RecA was detected using the antibody AK26326, AlpB 
using the antibody AK22727. Secondary antibodies used were horseradish peroxidase conjugated. For antibody 
detection Millipore Immobilon Western (Millipore) and GelDoc imaging (BioRad) were used. ImageLab soft-
ware 4.1 (BioRad) and 5.1 versions were used for semi-quantitative analysis of chemoluminescent signals, using 
StainFree protein staining28 as normalization factor, with a background correction of 10.
For an accurate comparison of signals, all proteins were detected on the same membrane. The protocols 
and buffers here mentioned were taken and adapted from recommended protocol published by Millipore in 
its “Protein Blotting Handbook” (found online at http://www.merckmillipore.com/DE/en/life-science-research/
protein-detection-quantification/western-blotting/protocols/q9ib.qB.710AAAFBRP0RRkww,nav). For reprobing 
of membranes without loss of signals, PVDF membranes were left to dry for 1 hour  at 37 °C after blot transfer and 
reactivated with methanol for 15–30 s before starting detection. Between protein detections we achieved removal 
of previous primary antibodies using a solution containing 1% SDS, 25 mM Glycine, pH 2 for 1 hour at room 
temperature. The order of detection was: Ⓟ-CagA (120–130 kDa, 4G10 (Millipore), mouse IgG), RecA (32 kDa, 
AK263, rabbit IgG), CagA (120–130 kDa, AK257, rabbit IgG), AlpB (51 kDa, AK277, Rabbit IgG) and Tubulin 
(68 kDa, (Sigma), mouse IgG).
References
1. Odenbreit, S. et al. Translocation of Helicobacter pylori CagA into gastric epithelial cells by type IV secretion. Science 287, 
1497–1500 (2000).
2. Selbach, M., Moese, S., Hauck, C. R., Meyer, T. F. & Backert, S. Src is the kinase of the Helicobacter pylori CagA protein in vitro and 
in vivo. J Biol.Chem. 277, 6775–6778 (2002).
3. Poppe, M., Feller, S. M., Romer, G. & Wessler, S. Phosphorylation of Helicobacter pylori CagA by c-Abl leads to cell motility. 
Oncogene. 26, 3462–3472 (2007).
4. Bagnoli, F., Buti, L., Tompkins, L., Covacci, A. & Amieva, M. R. Helicobacter pylori CagA induces a transition from polarized to 
invasive phenotypes in MDCK cells. Proc.Natl.Acad.Sci.USA 102, 16339–16344 (2005).
5. Saadat, I. et al. Helicobacter pylori CagA targets PAR1/MARK kinase to disrupt epithelial cell polarity. Nature 447, 330–333, doi: 
10.1038/nature05765 (2007).
6. Backert, S., Tegtmeyer, N. & Selbach, M. The versatility of Helicobacter pylori CagA effector protein functions: The master key 
hypothesis. Helicobacter 15, 163–176, doi: 10.1111/j.1523-5378.2010.00759.x (2010).
7. Jimenez-Soto, L. F. et al. Helicobacter pylori type IV secretion apparatus exploits beta1 integrin in a novel RGD-independent 
manner. PLoS Pathog 5, e1000684, doi: 10.1371/journal.ppat.1000684 (2009).
8. Kwok, T. et al. Helicobacter exploits integrin for type IV secretion and kinase activation. Nature. 449, 862–866 (2007).
9. Backert, S., Clyne, M. & Tegtmeyer, N. Molecular mechanisms of gastric epithelial cell adhesion and injection of CagA by 
Helicobacter pylori. Cell communication and signaling: CCS 9, 28, doi: 10.1186/1478-811X-9-28 (2011).
10. Belogolova, E. et al. Helicobacter pylori outer membrane protein HopQ identified as a novel T4SS-associated virulence factor. Cell 
Microbiol, doi: 10.1111/cmi.12158 (2013).
11. Jungblut, P. R. et al. Comparative proteome analysis of Helicobacter pylori. Mol Microbiol 36, 710–725 (2000).
www.nature.com/scientificreports/
7Scientific RepoRts | 6:23227 | DOI: 10.1038/srep23227
12. Schlumberger, M. C. et al. Real-time imaging of type III secretion: Salmonella SipA injection into host cells. Proc Natl Acad Sci USA 
102, 12548–12553, doi: 10.1073/pnas.0503407102 (2005).
13. Van Engelenburg, S. B. & Palmer, A. E. Quantification of real-time Salmonella effector type III secretion kinetics reveals differential 
secretion rates for SopE2 and SptP. Chem Biol 15, 619–628, doi: 10.1016/j.chembiol.2008.04.014 (2008).
14. Posselt, G., Backert, S. & Wessler, S. The functional interplay of Helicobacter pylori factors with gastric epithelial cells induces a 
multi-step process in pathogenesis. Cell communication and signaling: CCS 11, 77, doi: 10.1186/1478-811X-11-77 (2013).
15. Jimenez-Soto, L. F., Clausen, S., Sprenger, A., Ertl, C. & Haas, R. Dynamics of the Cag-type IV secretion system of Helicobacter 
pylori as studied by bacterial co-infections. Cell Microbiol, doi: 10.1111/cmi.12166 (2013).
16. Ishijima, N. et al. BabA-mediated adherence is a potentiator of the Helicobacter pylori type IV secretion system activity. J Biol Chem 
286, 25256–25264, doi: 10.1074/jbc.M111.233601 (2011).
17. Tan, S., Noto, J. M., Romero-Gallo, J., Peek, R. M., Jr. & Amieva, M. R. Helicobacter pylori perturbs iron trafficking in the epithelium 
to grow on the cell surface. PLoS Pathog 7, e1002050, doi: 10.1371/journal.ppat.1002050 (2011).
18. Umehara, S., Higashi, H., Ohnishi, N., Asaka, M. & Hatakeyama, M. Effects of Helicobacter pylori CagA protein on the growth and 
survival of B lymphocytes, the origin of MALT lymphoma. Oncogene 22, 8337–8342 (2003).
19. Murata-Kamiya, N. et al. Helicobacter pylori CagA interacts with E-cadherin and deregulates the beta-catenin signal that promotes 
intestinal transdifferentiation in gastric epithelial cells. Oncogene. 26, 4617–4626 (2007).
20. El-Etr, S. H., Mueller, A., Tompkins, L. S., Falkow, S. & Merrell, D. S. Phosphorylation-Independent Effects of CagA during 
Interaction between Helicobacter pylori and T84 Polarized Monolayers. Journal of Infectious Diseases 190, 1516–1523, doi: 
10.1086/424526 (2004).
21. Amieva, M. R. et al. Disruption of the epithelial apical-junctional complex by Helicobacter pylori CagA. Science 300, 1430–1434, 
doi: 10.1126/science.1081919 (2003).
22. Fischer, W. et al. Systematic mutagenesis of the Helicobacter pylori cag pathogenicity island: essential genes for CagA translocation 
in host cells and induction of interleukin-8. Mol.Microbiol. 42, 1337–1348 (2001).
23. Jimenez-Soto, L. F. et al. Effects of cholesterol on Helicobacter pylori growth and virulence properties in vitro. Helicobacter 17, 
133–139, doi: 10.1111/j.1523-5378.2011.00926.x (2012).
24. Takagi, J., Erickson, H. P. & Springer, T. A. C-terminal opening mimics ‘inside-out’ activation of integrin alpha5beta1. Nat Struct Biol 
8, 412–416, doi: 10.1038/87569 (2001).
25. Ahn, T., Yim, S. K., Choi, H. I. & Yun, C. H. Polyacrylamide gel electrophoresis without a stacking gel: use of amino acids as 
electrolytes. Anal Biochem 291, 300–303, doi: 10.1006/abio.2001.5038 (2001).
26. Fischer, W. & Haas, R. The RecA protein of Helicobacter pylori requires a posttranslational modification for full activity. J.Bacteriol. 
186, 777–784 (2004).
27. Odenbreit, S., Till, M., Hofreuter, D., Faller, G. & Haas, R. Genetic and functional characterization of the alpAB gene locus essential 
for the adhesion of Helicobacter pylori to human gastric tissue. Mol.Microbiol. 31, 1537–1548 (1999).
28. Ladner, C. L., Yang, J., Turner, R. J. & Edwards, R. A. Visible fluorescent detection of proteins in polyacrylamide gels without 
staining. Anal Biochem 326, 13–20, doi: 10.1016/j.ab.2003.10.047 (2004).
Acknowledgements
This work was supported by research grants of the DFG JI 221/1-1 to LFJS and HA 2697/17-1 to RH.
Author Contributions
Experimental procedures and design (L.F.J.S.), manuscript preparation and completion (L.F.J.S. and R.H.)
Additional Information
Competing financial interests: The authors declare no competing financial interests.
How to cite this article: Jiménez-Soto, L. F. and Haas, R. The CagA toxin of Helicobacter pylori: abundant 
production but relatively low amount translocated. Sci. Rep. 6, 23227; doi: 10.1038/srep23227 (2016).
This work is licensed under a Creative Commons Attribution 4.0 International License. The images 
or other third party material in this article are included in the article’s Creative Commons license, 
unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, 
users will need to obtain permission from the license holder to reproduce the material. To view a copy of this 
license, visit http://creativecommons.org/licenses/by/4.0/
